Column: Dos, Don’ts and What-Ifs
Instinctively, I am not the most open-to-new-ideas/new-things kind of person. However, an unexpected diagnosis of stage IV, non small-cell lung cancer (NSCLC) at age 54 and a half – along with its equally unexpected “13-month to two-year prognosis,” changes a few things.
Accreditation: A Mixed Bag
Commentary
The Virginia Department of Education has issued accreditation reports on our public schools. For our area, the results are mixed.
The Never Never Bond
The British call credit card charges the “Never Never.” That is the attitude of the Fairfax Board of Supervisors (the BOS) with the current $100 million bond issue on the ballot.
A Better Tribute?
This is in response to H. Jay Spiegel’s letter in the October 23, 2014, issue of the Mount Vernon Gazette.
The Dysfunction In the Senate
(and why we need Ed Gillespie for Virginia)
The Senate Majority Leader Mister Reid is a master of the partisan deed.
Running Out of Efficacy
Not that I’m the least bit worried (actually, I’m the most bit worried), but surviving a terminal cancer diagnosis years beyond one’s original prognosis does present its own unique set of problems. Most notably, and most personally for me, they concern treatment options. Specifically, what drugs, targeted or otherwise, can be infused and/or swallowed (when in pill form, like Tarceva) and for how long, when signs of internal organ damage are indicated on regular lab tests?
Column: Running Out of Efficacy
Not that I’m the least bit worried (actually, I’m the most bit worried), but surviving a terminal cancer diagnosis years beyond one’s original prognosis does present its own unique set of problems.
Editorial: Change for the Better in Fairfax County Schools
Later start times, full-day Mondays; who knows, next maybe gifted-and-talented programs for poor students?
Who says big bureaucracies can’t make big changes? One year into the tenure of Karen Garza, we have two huge changes that between them impact almost every single student, every family with children in Fairfax County Public Schools.
Column: Self-Indulgent or Self-Effacing
After re-reading last week’s column: “Not in the Mood,” I began wondering if that column had strayed beyond the boundaries, so to speak, and was too much about me and not enough about my circumstances.
Self-Indulgent or Self-Effacing
After re-reading last week’s column: “Not in the Mood,” I began wondering if that column had strayed beyond the boundaries, so to speak, and was too much about me and not enough about my circumstances. Certainly I understand, given my column’s recurring theme, that the subjects of me and my circumstances – and the personal stories I share with you regular readers – are basically the same. Still, I never want the content to be considered important because it’s MY life that’s being profiled. Quite the contrary. If the columns were any more about me, you wouldn’t be interested.
Editorial: Yes to Fairfax Transportation Bond
$84 million for pedestrian, bike and trail improvements.
Of more than 75 projects included in the current proposal, on the ballot for Nov. 4, all but seven are designed to make Fairfax County safer and more inviting for pedestrians and bicyclists.
U.S. 1 Transit Study: Time to Speak Up
Last week, Virginia’s Department of Rail and Public Transit held the last public hearing on the U.S. 1 Multimodal Transit Study. This study will determine the most appropriate road configuration, mode of transit and accompanying land uses for the U.S. 1 corridor for the next 30 years. As the study ends, public input is absolutely critical.
Editorial: Coming - Children’s Connection
During the last week of each year, The Connection devotes its entire issue to the creativity of local students and children. The results are always remarkable. It is a keepsake edition for many families.
Column: Not in the Mood
Sometimes, believe it or not, I’m not in the mood to be a terminal cancer patient (duh). Not that the effect is particularly tangible, but the weight of it, as well as the associated waits I’ve occasionally written about, can get awfully heavy.
Column: Week Of, Weak On, Week Off
This column completes the three-week arc which describes what I have endured mostly successfully for approximately five years now: chemotherapy every three weeks – with one year off for good behavior (not really good behavior; the year off was to switch to a twice-daily pill, Tarceva, to be taken at home, since the previous treatment was no longer stemming the tide). It’s been my experience that these anti-cancer drugs don’t exactly work forever.